Overview :
IARC classified hydrochlorothiazide, voriconazole, and tacrolimus as "carcinogenic to humans" (Group 1). All three feature on the WHO Model List of Essential Medicines and are widely prescribed in India for hypertension, fungal infections, and organ transplant rejection. Experts urge patients not to stop treatment without medical advice.
Understanding IARC Classification
Think of IARC classification as a safety alert, not a death sentence. Group 1 means "we have sufficient evidence this substance can cause cancer." But hazard ≠ risk. Sunlight is a Group 1 carcinogen—yet we don't stop going outside. Dose, duration, and individual factors determine actual risk.
The Three Drugs
-
Hydrochlorothiazide Blood pressure medication—millions take it daily. Discontinuing without replacement can trigger strokes or heart attacks.
-
Voriconazole Life-saving antifungal for serious infections. Stopping can be fatal.
-
Tacrolimus Prevents organ rejection. Transplant patients depend on it—stopping means losing the transplanted organ.
WHO Essential Medicines Status
All three drugs feature on the WHO Model List of Essential Medicines. This means WHO considers them indispensable for basic healthcare. The classification creates a paradox—essential drugs with cancer risk.
The Indian Context
Hydrochlorothiazide remains a cornerstone of hypertension treatment in India. It's inexpensive and works in combination with other drugs. For many patients, affordable options are limited. The classification must be weighed against access to alternatives.
Medical Consensus
Experts uniformly advise: do not stop these medicines abruptly. The benefits for hypertension, fungal infections, and transplant rejection often outweigh cancer risks. Doctors may consider alternatives for long-term use, but only under medical supervision.
Exam-Focused Points :
-
Three drugs Hydrochlorothiazide (hypertension), Voriconazole (antifungal), Tacrolimus (immunosuppressant for transplants)
-
Classification Group 1: "Carcinogenic to humans" by IARC (WHO's specialised cancer research agency)
-
WHO Essential Medicines All three appear on WHO Model List of Essential Medicines
-
Indian relevance Hydrochlorothiazide remains an inexpensive, widely available hypertension treatment, often in combination with other drugs
-
Expert advice Patients should not stop treatment without consulting their doctor
-
Risk context IARC classification identifies hazard, not individual risk—benefits often outweigh cancer risk for these essential medicines
-
Medical principle Never discontinue essential medications based solely on classification; discuss with prescribing physician
FAQs :
Q1: Which three drugs did IARC classify as carcinogenic?
Hydrochlorothiazide, voriconazole, and tacrolimus.
Q2: What does Group 1 classification mean?
"Carcinogenic to humans"—sufficient evidence of cancer-causing potential exists.
Q3: What is IARC?
International Agency for Research on Cancer—WHO's specialised cancer research agency.
Q4: Should patients stop taking these medicines?
No. Experts urge patients not to stop treatment without consulting their doctor.
Q5: Are these medicines used in India?
Yes. All three are routinely prescribed in India; hydrochlorothiazide remains an inexpensive, widely available hypertension treatment.
Month: Current Affairs - Aug 05, 2026
Category: Health and Medicine